Skip to main content
OpenTrials
Completed

NCT Number: NCT05771350

Online Hemodiafiltration Versus Hemodialysis in Removal of Indoxyl Sulfate in Chronic Hemodialysis Patients

this study aimed to compare the removal of indoxyl sulphate between hemodiafiltration, high flux hemodialysis and low flux hemodialysis

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • maintenance hemodialysis patients aged more than 18 years

Exclusion criteria

  • active illnesses, hospitalization, malignancy

Treatment and study plan

online hemodiafiltration

Procedure

20 patients on regular hemodialysis received online hemodiafiltration

high flux hemodialysis

Procedure

20 patients on regular hemodialysis received high flux hemodialysis

low flux hemodialysis

Procedure

20 patients on regular hemodialysis received low flux hemodialysis

Primary outcomes

  1. dialytic removal of indoxyl sulpahte

    Time frame: one month when all samples were collected

    assessed by the reduction ration of indoxyl sulphate

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Official study title

Hemodiafiltration Versus Hemodialysis in Removal of Indoxyl Sulfate in Chronic Hemodialysis Patients

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Mar 16, 2023
Registry last updated
Mar 16, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.